Associate Professor, Medicine, UCSF School of Medicine
Pulmonology
Dr. Paul J. Wolters, MD
|
|
Give Review
Paul Wolters practices Pulmonology. He researched medicine at University of Minnesota Medical School. University of Minnesota Medical School is ranked 40/10 in Research/PrimaryCare. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Paul Wolters is a published MD. He published 66 publications, including: 'Regulated expression, processing, and secretion of dog mast cell dipeptidyl peptidase I.' He is registered with Medicare.
Publications
- Frailty Phenotypes, Disability, and Outcomes in Adult Candidates for Lung Transplantation.
- Overexpression of Inhibitor of DNA-Binding 2 Attenuates Pulmonary Fibrosis through Regulation of c-Abl and Twist.
- Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic Pulmonary fibrosis.
- Endogenously Expressed IL-13Rα2 Attenuates IL-13-Mediated Responses but Does Not Activate Signaling in Human Lung Fibroblasts.
- Selective Targeting of TGF-β Activation to Treat Fibroinflammatory Airway Disease.
- Effect of telomere length on survival in patients with idiopathic Pulmonary fibrosis: an observational cohort study with independent validation.
- Dipeptidyl Peptidase I Controls Survival from Klebsiella pneumoniae Lung Infection by Processing Surfactant Protein D.
- Diagnosis of idiopathic Pulmonary fibrosis with high-resolution CT.
- Increased susceptibility to Klebsiella Pneumonia and mortality in GSNOR-deficient mice.
- BPIFB1 is a Lung-specific autoantigen associated with interstitial Lung disease.
- Pathogenesis of Idiopathic Pulmonary Fibrosis.
- Noradrenergic Neurons Regulate Monocyte Trafficking and Mortality during Gram-Negative Peritonitis in Mice.
- Genome-wide association study identifies multiple susceptibility loci for Pulmonary fibrosis.
- Prevalence and clinical significance of circulating autoantibodies in idiopathic Pulmonary fibrosis.
- Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contraction.
- Lung mast cell density defines a subpopulation of patients with idiopathic Pulmonary fibrosis.
- Interleukin-1{beta} induces increased transcriptional activation of the transforming growth factor-{beta} activating integrin subunit {beta}8 through altering chromati...
- Gastroesophageal Reflux Therapy is Associated with Longer Survival in Idiopathic Pulmonary Fibrosis.
- Systemic mast cell degranulation increases mortality during polymicrobial septic peritonitis in mice.
- Alveolar Epithelial Cells Express Mesenchymal Proteins in Patients With Idiopathic Pulmonary Fibrosis.
- Viral infection in acute exacerbation of idiopathic Pulmonary fibrosis.
- Parasitic Infection improves survival from septic peritonitis by enhancing mast cell responses to bacteria in mice.
- Transcription of the transforming growth factor beta activating integrin beta8 subunit is regulated by SP3, AP-1, and the p38 pathway.
- Plasma biomarker profiles in acute exacerbation of idiopathic Pulmonary fibrosis.
- Undifferentiated connective tissue disease-associated interstitial Lung disease: changes in Lung function.
- Could N-acetylcysteine slow progression of idiopathic Pulmonary fibrosis by inhibiting EMT?
- Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice.
- Neutrophil-derived IL-6 limits alveolar barrier disruption in experimental ventilator-induced Lung injury.
- Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and Pulmonary fibrosis.
- Mast cell IL-6 improves survival from Klebsiella Pneumonia and sepsis by enhancing neutrophil killing.
- Relationships between early inflammatory response to bleomycin and sensitivity to Lung fibrosis: a role for dipeptidyl-peptidase I and tissue inhibitor of metalloprote...
- Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice.
- Idiopathic nonspecific interstitial pneumonia: Lung manifestation of undifferentiated connective tissue disease?
- Mast cells promote atheroSclerosis by releasing proinflammatory cytokines.
- Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis.
- Clinical problem-solving. Anchors away.
- Neutrophil histamine contributes to inflammation in mycoplasma Pneumonia.
- Cutting edge: Deficiency of macrophage migration inhibitory factor impairs murine airway allergic responses.
- Alveolar epithelial cell mesenchymal transition develops in vivo during Pulmonary fibrosis and is regulated by the extracellular matrix.
- Mast cells protect mice from Mycoplasma Pneumonia.
- Mast cell dipeptidyl peptidase I mediates survival from sepsis.
- Structure and activity of human pancreasin, a novel tryptic serine peptidase expressed primarily by the pancreas.
- Accumulation of BDCA1+ Dendritic Cells in Interstitial Fibrotic Lung Diseases and Th2-High Asthma.
- High-resolution organellar genome analysis of Triticum and Aegilops sheds new light on cytoplasm evolution in wheat.
- Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV Infection.
- Cardiac antisecretory peptide inhibits intestinal chloride secretion.
- No effect of bipolar interferential electrotherapy and pulsed ultrasound for soft tissue shoulder disorders: a randomised controlled trial.
- Importance of lysosomal cysteine proteases in Lung disease.
- Neurofibromatosis-associated Lung disease: a case series and literature review.
- Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic Pulmonary fibrosis.
- Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients.
- Angiotensin II generation by mast cell alpha- and beta-chymases.
- Mouse and human Lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin αvβ8-mediated activation of TGF-β.
- Mast cell cathepsins C and S control levels of carboxypeptidase A and the chymase, mouse mast cell protease 5.
- Dipeptidyl peptidase I cleaves matrix-associated proteins and is expressed mainly by mast cells in normal dog airways.
- Tissue-selective mast cell reconstitution and differential Lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice.
- Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families.
- Mfge8 diminishes the severity of tissue fibrosis in mice by binding and targeting collagen for uptake by macrophages.
- Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice.
- Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta.
- Regulated expression, processing, and secretion of dog mast cell dipeptidyl peptidase I.
- Lys40 but not Arg143 influences selectivity of angiotensin conversion by human alpha-chymase.
- c-Kit immunophenotyping and metalloproteinase expression profiles of mast cells in interstitial lung Diseases.
- Use of mycophenolate mofetil to treat scleroderma-associated interstitial Lung disease.
- Cathepsins L and S are not required for activation of dipeptidyl peptidase I (cathepsin C) in mice.
Schools
University Of Minnesota Medical School
University Of Co School Of Med
Procedures Preformed
- Bronchoscopy
- Ventilation Management
Conditions Treated
- Acidosis
- Asthma
- Atelectasis
- Bronchiectasis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
Accepted Insurances
- Aetna HMO
- Basic HMO
- Choice Plus POS II
- Vitalidad Plus California Con Aetna
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select Plus HMO
- Select PPO
- Access Plus Savenet
- Enhanced Exclusive for Small Business HMO
- Local Access Plus HMO
- Brown & Toland Physicians
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Blue & Gold HMO
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- Medicare Advantage PFFS
- WholeCare Network HMO
- Humana
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Colorado -
University of Minnesota Medical School
Hospital
-
San Francisco General Hospital and Trauma Center -
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1861443731 | |
| NPPES Provider LastName | WOLTERS | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 941432202 | |
| NPPES Provider State | CA | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 55.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861443731 |
| Last Name Of The Provider | WOLTERS |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Kamran Atabai, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rebecca E. Schane, MD |
|
|
Dr. Michael R. Flick, MD |
|
|
Dr. Rondall K. Lane, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard M. Schlobohm, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sofya Tokman, MD |
|
|
Dr. Binbin Wang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Morton J. Stein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George Su, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John L. Davis Jr., MD |
|
|
Dr. Steven R. Hays, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne L. Meneghetti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher J. Ryerson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine A. Kinghorn, MD |
|
|
Dr. Rajeev Venkayya, MD
This Doctor is OpenDoctor Recommended.
|